We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

19 hedge funds and large institutions have $17.3M invested in Albireo Pharma Inc in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

563% more capital invested

Capital invested by funds: $2.61M → $17.3M (+$14.7M)

14% less funds holding

Funds holding: 22 → 19 (-3)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

57% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 7

Holders
19
Holders Change
-3
Holders Change %
-13.64%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
7
Closed
7
Calls
$617K
Puts
–
Net Calls
+$617K
Net Calls Change
+$606K

Top Buyers

Rank Fund Capital Flow
1
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
+$16.1M
2
Renaissance Technologies
Renaissance Technologies
New York
+$360K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$192K
4
Deutsche Bank
Deutsche Bank
Germany
+$25.9K
5
Morgan Stanley
Morgan Stanley
New York
+$9.36K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$374K
2
BFA
BlackRock Fund Advisors
California
-$87.3K
3
Citadel Advisors
Citadel Advisors
Florida
-$20K
4
Northern Trust
Northern Trust
Illinois
-$20K
5
UBS Group
UBS Group
Switzerland
-$19.3K

ALBO Hedge Fund Activity: Q4 2016 in Review

19 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q4 2016, worth a combined $17.3M — up 563% from $2.61M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ALBO and 4 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 3 added.

The largest buyer was TPG Group Holdings (SBS) Advisors, opening a new position worth an estimated $16.1M. The largest seller was Vanguard Group, cutting an estimated $374K.

  • 19 institutional investors held Albireo Pharma Inc (ALBO) as of Q4 2016, down from 22 in Q3 2016.
  • Funds reported $17.3M of Albireo Pharma Inc stock for Q4 2016, up 563% quarter-over-quarter.
  • 4 funds opened new Albireo Pharma Inc positions in Q4 2016 and 7 closed out, a net change of -3 holders.
  • The largest Albireo Pharma Inc buyer in Q4 2016 was TPG Group Holdings (SBS) Advisors, an estimated $16.1M added.
  • The largest Albireo Pharma Inc seller in Q4 2016 was Vanguard Group, an estimated $374K sold.

Based on aggregated 13F filings for Q4 2016.